In a report released today, Trung Huynh from Credit Suisse maintained a Buy rating on Pfizer (PFE - Research Report), with a price target of $55.00. The company's shares closed yesterday at $50.73.Huynh covers the Healthcare sector, focusing on stocks such as Pfizer, Eli Lilly & Co, and Amgen. According to TipRanks, Huynh has an average return of 12.5% and a 78.95% success rate on recommended stocks. Pfizer has an analyst consensus of Moderate Buy, with a price target consensus of $52.00.See Insiders’ Hot Stocks on TipRanks >> Based on Pfizer's latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $22.
https://www.tipranks.com/news/blurbs/credit-suisse-remains-a-buy-on-pfizer-pfe?utm_source=advfn.com&utm_medium=referral
Pfizer (NYSE:PFE)
過去 株価チャート
から 1 2023 まで 2 2023 Pfizerのチャートをもっと見るにはこちらをクリック
Pfizer (NYSE:PFE)
過去 株価チャート
から 2 2022 まで 2 2023 Pfizerのチャートをもっと見るにはこちらをクリック